Steglujan 15-100mg Tablets

Manufacturer MERCK SHARP & DOHME Active Ingredient Ertugliflozin and Sitagliptin(er too gli FLOE zin & sit a GLIP tin) Pronunciation er too gli FLOE zin & sit a GLIP tin
It is used to help control blood sugar in people with type 2 diabetes.
đŸˇī¸
Drug Class
Antidiabetic, combination
đŸ§Ŧ
Pharmacologic Class
Sodium-glucose co-transporter 2 (SGLT2) inhibitor and Dipeptidyl peptidase-4 (DPP-4) inhibitor
🤰
Pregnancy Category
Category D
✅
FDA Approved
Dec 2017
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Steglujan is a medication used to help adults with type 2 diabetes manage their blood sugar. It contains two medicines: ertugliflozin and sitagliptin. Ertugliflozin works by helping your kidneys remove more sugar from your body through your urine. Sitagliptin works by increasing natural substances in your body that help control blood sugar, especially after meals.
📋

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely. You can take this medication with or without food, and it's recommended to take it in the morning. Continue taking your medication as directed by your doctor or healthcare provider, even if you're feeling well.

It's also important to stay hydrated by drinking plenty of non-caffeinated liquids, unless your doctor advises you to limit your fluid intake.

Storing and Disposing of Your Medication

To keep your medication safe and effective, store it at room temperature in a dry place, away from the bathroom. Keep all medications out of the reach of children and pets, and store them in a secure location. When you're finished with your medication or it's expired, dispose of it properly. Do not flush it down the toilet or pour it down the drain unless instructed to do so by your doctor or pharmacist. If you're unsure about the best way to dispose of your medication, ask your pharmacist for guidance. You may also want to check if there are any drug take-back programs in your area.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for a missed one.
💡

Lifestyle & Tips

  • Take Steglujan exactly as prescribed, usually once daily in the morning, with or without food.
  • Maintain a healthy diet as recommended by your doctor or dietitian.
  • Engage in regular physical activity.
  • Stay well-hydrated to reduce the risk of dehydration and kidney problems.
  • Monitor your blood sugar levels regularly as advised by your healthcare provider.
  • Practice good hygiene, especially genital hygiene, to reduce the risk of infections.
💊

Available Forms & Alternatives

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Ertugliflozin 15 mg/Sitagliptin 100 mg orally once daily in the morning, with or without food.
Dose Range: 15 - 100 mg

Condition-Specific Dosing:

initial_therapy: Not recommended as initial therapy for type 2 diabetes.
add_on_therapy: For patients inadequately controlled on ertugliflozin or sitagliptin alone, or for those already on both as separate tablets.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No dose adjustment required for eGFR â‰Ĩ 60 mL/min/1.73 m2.
Moderate: Not recommended for initiation in patients with eGFR < 60 mL/min/1.73 m2. If eGFR falls persistently below 60 mL/min/1.73 m2 during treatment, discontinue Steglujan.
Severe: Contraindicated in patients with eGFR < 45 mL/min/1.73 m2, end-stage renal disease (ESRD), or on dialysis.
Dialysis: Contraindicated.

Hepatic Impairment:

Mild: No dose adjustment required.
Moderate: No dose adjustment required.
Severe: Not studied for ertugliflozin. No dose adjustment for sitagliptin. Use with caution.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Steglujan combines two antihyperglycemic agents with complementary mechanisms of action: Ertugliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, and Sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor. Ertugliflozin reduces renal reabsorption of filtered glucose and lowers the renal threshold for glucose (RTG), thereby increasing urinary glucose excretion (UGE) and lowering blood glucose concentrations. Sitagliptin inhibits the enzyme DPP-4, which normally inactivates incretin hormones (glucagon-like peptide-1 [GLP-1] and glucose-dependent insulinotropic polypeptide [GIP]). By inhibiting DPP-4, sitagliptin increases the levels of active incretin hormones, leading to enhanced glucose-dependent insulin release from pancreatic beta cells and suppressed glucagon secretion from pancreatic alpha cells, thereby improving glycemic control.
📊

Pharmacokinetics

Absorption:

Bioavailability: Ertugliflozin: ~100%; Sitagliptin: ~87%
Tmax: Ertugliflozin: 1 hour; Sitagliptin: 1-4 hours
FoodEffect: No clinically meaningful effect of food on the pharmacokinetics of either ertugliflozin or sitagliptin.

Distribution:

Vd: Ertugliflozin: 85.5 L; Sitagliptin: 198 L
ProteinBinding: Ertugliflozin: 93.6%; Sitagliptin: 38%
CnssPenetration: Limited for both

Elimination:

HalfLife: Ertugliflozin: 17 hours; Sitagliptin: 12.4 hours
Clearance: Ertugliflozin: 11.3 L/hr; Sitagliptin: 350 mL/min
ExcretionRoute: Ertugliflozin: Feces (41.5%), Urine (50.2%); Sitagliptin: Urine (79%), Feces (13%)
Unchanged: Ertugliflozin: 34% (urine); Sitagliptin: 79% (urine)
âąī¸

Pharmacodynamics

OnsetOfAction: Ertugliflozin: Within hours; Sitagliptin: Within 24 hours
PeakEffect: Ertugliflozin: 1-2 hours; Sitagliptin: 1-4 hours
DurationOfAction: Ertugliflozin: 24 hours; Sitagliptin: 24 hours
Confidence: High

Safety & Warnings

âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Allergic Reaction: Rash, hives, itching, red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing, swallowing, or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.
Fluid and Electrolyte Problems: Mood changes, confusion, muscle pain or weakness, fast or abnormal heartbeat, severe dizziness or passing out, increased thirst, seizures, feeling very tired or weak, decreased appetite, unable to pass urine or change in the amount of urine produced, dry mouth, dry eyes, or severe upset stomach or throwing up.
Kidney Problems: Unable to pass urine, change in how much urine is passed, blood in the urine, or a big weight gain.
Too Much Acid in the Blood (Acidosis): Confusion; fast breathing; fast heartbeat; a heartbeat that does not feel normal; very bad stomach pain, upset stomach, or throwing up; feeling very sleepy; shortness of breath; or feeling very tired or weak.
Urinary Tract Infection (UTI): Blood in the urine, burning or pain when passing urine, feeling the need to pass urine often or right away, fever, lower stomach pain, or pelvic pain.
Vaginal Yeast Infection: Itching, bad odor, or discharge. Report these symptoms to your doctor.
Yeast Infection of the Penis: Pain, swelling, rash, or discharge. Report these symptoms to your doctor.
Low Blood Sugar: Dizziness, headache, feeling sleepy or weak, shaking, fast heartbeat, confusion, hunger, or sweating. If you experience any of these symptoms, contact your doctor right away and follow their instructions for managing low blood sugar, which may include taking glucose tablets, liquid glucose, or some fruit juices.
Pancreas Problems (Pancreatitis): Severe stomach pain, severe back pain, or severe upset stomach or throwing up. These can be signs of severe and potentially deadly pancreas problems.
Heart Failure: If you have a history of heart failure or kidney problems, inform your doctor. Call your doctor right away if you feel very tired or experience shortness of breath, a big weight gain, or swelling in the arms or legs.
Increased Risk of Lower Limb Amputations: Toe and foot amputations have occurred most often. Discuss foot care with your doctor, especially if you have a history of amputation, blood vessel disease, nerve disease, or a foot ulcer caused by diabetes. Report any new pain or tenderness, sores or ulcers, or infections in your legs or feet to your doctor immediately.
Severe Joint Pain: Very bad joint pain or any joint pain that does not go away. Contact your doctor right away if you experience this symptom.
Bullous Pemphigoid: A skin reaction that can cause blisters or skin breakdown. Sometimes, hospitalization is required. Call your doctor right away if you notice blisters or skin breakdown.
Rare but Serious Infection: If your genitals or the area between your genitals and rectum becomes tender, red, or swollen, and you have a fever or do not feel well, seek medical help immediately. This infection can be deadly.
Severe Skin Reaction (Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis): Red, swollen, blistered, or peeling skin (with or without fever); red or irritated eyes; or sores in your mouth, throat, nose, or eyes. This reaction can cause severe health problems that may not go away and can be fatal. Seek medical help right away if you notice any of these symptoms.

Other Side Effects

Most people do not experience side effects or only have minor ones. However, if you are bothered by any of the following side effects or if they do not go away, contact your doctor or seek medical help:

Signs of a common cold
Nose or throat irritation
Headache
Upset stomach
Diarrhea

These are not all the possible side effects. If you have questions about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Signs of dehydration: Dizziness, lightheadedness, feeling faint, especially when standing up.
  • Signs of urinary tract infection (UTI): Burning sensation when urinating, frequent urination, cloudy urine, pain in the pelvis or back.
  • Signs of genital yeast infection: Itching, redness, swelling, or discharge in the genital area.
  • Signs of diabetic ketoacidosis (DKA): Nausea, vomiting, stomach pain, excessive thirst, frequent urination, unusual tiredness, fruity-smelling breath.
  • Signs of pancreatitis: Severe pain in your stomach area that may spread to your back, with or without vomiting.
  • Signs of hypoglycemia (low blood sugar): Shakiness, sweating, confusion, dizziness, hunger, fast heartbeat. Carry a source of sugar (e.g., glucose tablets, fruit juice) for immediate treatment.
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following conditions to ensure safe treatment:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Describe the allergic reaction you experienced, including the symptoms that occurred.
If you have type 1 diabetes, as this medication is not intended to treat this condition.
If you have a condition that affects the acidity of your blood.
If you have kidney disease or are undergoing dialysis.
If you have liver disease.
If you are dehydrated, as this may require special consideration.
If you are pregnant or think you might be pregnant. Do not take this medication during the second or third trimester of pregnancy.
If you are breastfeeding, as you should not breastfeed while taking this medication.

Additionally, it is crucial to discuss all your medications, including prescription and over-the-counter drugs, natural products, and vitamins, with your doctor and pharmacist. This includes:

All prescription medications you are currently taking.
Over-the-counter medications, such as pain relievers or antihistamines.
Natural products, including herbal supplements or vitamins.
Any health problems you have, as they may interact with this medication.

Do not start, stop, or change the dose of any medication without first consulting your doctor to ensure your safety. This list is not exhaustive, and your doctor and pharmacist need to be aware of all your medications and health conditions to determine if it is safe for you to take this medication.
âš ī¸

Precautions & Cautions

Important Warnings and Precautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Your doctor may advise you to stop taking this drug before certain surgical procedures, and will provide guidance on when to resume taking it after the surgery or procedure.

Monitoring and Laboratory Tests

Your doctor will instruct you to have regular blood work and other laboratory tests to monitor your condition. Be aware that this medication may affect the results of certain lab tests, so it is crucial to inform all your healthcare providers and laboratory personnel that you are taking this drug.

Blood Sugar Control

During times of stress, such as fever, infection, injury, or surgery, it may be more challenging to control your blood sugar levels. Changes in physical activity, exercise, or diet can also impact your blood sugar levels. Follow your doctor's instructions for monitoring your blood sugar levels, and discuss the most suitable glucose tests to use.

Safety Precautions

Do not drive if your blood sugar levels are low, as this can increase the risk of accidents. To minimize the risk of dizziness or fainting, rise slowly from a sitting or lying down position, and exercise caution when climbing stairs.

Diet and Exercise

Adhere to the diet and exercise plan recommended by your doctor. If you are on a low-salt or salt-free diet, consult with your doctor before making any changes. Additionally, discuss the consumption of alcohol with your doctor before drinking.

Special Situations

If you are unable to eat or drink normally, such as during illness, fasting, or certain medical procedures, consult with your doctor for guidance. In hot weather or during physical activity, drink plenty of fluids to prevent dehydration. If you experience vomiting, diarrhea, or are unable to drink liquids, contact your doctor to avoid dehydration, which can lead to low blood pressure or worsen kidney problems.

Potential Side Effects

High cholesterol has been reported in patients taking this medication. If you have concerns, discuss them with your doctor. Additionally, this drug can increase the risk of ketoacidosis (too much acid in the blood or urine), which can be life-threatening and may require hospitalization. This risk is higher in patients with diabetes, pancreas problems, or those who are sick, dehydrated, or have skipped meals. If you use insulin, taking less than the prescribed dose or missing a dose can also increase the risk of ketoacidosis. Monitor your ketone levels as instructed by your doctor, and seek medical attention if you have questions or concerns.

Urinary Tract Infections and Kidney Problems

Severe urinary tract infections (UTIs) have been reported in patients taking this medication, and in some cases, hospitalization was necessary. Kidney problems have also occurred, which may require hospitalization or dialysis.

Special Populations

If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects. This medication may harm an unborn baby if taken during pregnancy. If you become pregnant or suspect you are pregnant while taking this medication, contact your doctor immediately.
🆘

Overdose Information

Overdose Symptoms:

  • Hypoglycemia (if taken with insulin or sulfonylureas)
  • Volume depletion/dehydration
  • Electrolyte imbalances

What to Do:

In case of overdose, contact your poison control center at 1-800-222-1222 or seek immediate medical attention. Treatment is supportive and based on symptoms. Correct dehydration and electrolyte imbalances as needed. Monitor blood glucose.

Drug Interactions

🔴

Major Interactions

  • Diuretics (e.g., loop diuretics, thiazide diuretics): Increased risk of volume depletion and orthostatic hypotension due to additive diuretic effect of ertugliflozin.
  • Insulin and Insulin Secretagogues (e.g., sulfonylureas): Increased risk of hypoglycemia when used in combination with sitagliptin. A lower dose of insulin or sulfonylurea may be required.
🟡

Moderate Interactions

  • Digoxin: Sitagliptin can slightly increase digoxin concentrations. Monitor digoxin levels when initiating Steglujan or changing dose.
  • Lithium: SGLT2 inhibitors may decrease lithium levels due to increased urinary excretion. Monitor lithium levels frequently.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Renal function (eGFR)

Rationale: To assess kidney function and determine appropriate dosing or contraindication.

Timing: Prior to initiation of therapy.

HbA1c and Fasting Plasma Glucose

Rationale: To establish baseline glycemic control.

Timing: Prior to initiation of therapy.

Volume status/Blood pressure

Rationale: To assess risk of volume depletion and orthostatic hypotension.

Timing: Prior to initiation of therapy.

📊

Routine Monitoring

HbA1c

Frequency: Every 3-6 months, or more frequently as needed to assess glycemic control.

Target: Individualized, typically <7%

Action Threshold: If target not met, consider dose adjustment or additional therapy.

Renal function (eGFR)

Frequency: At least annually, or more frequently in patients with impaired renal function or risk factors for renal decline.

Target: Maintain eGFR â‰Ĩ 60 mL/min/1.73 m2 for continued use.

Action Threshold: Discontinue if eGFR falls persistently below 60 mL/min/1.73 m2.

Signs/symptoms of volume depletion (e.g., dizziness, orthostatic hypotension)

Frequency: Regularly, especially during initiation and dose titration.

Target: Not applicable

Action Threshold: If symptoms occur, assess volume status and consider dose adjustment of Steglujan or concomitant diuretics.

Signs/symptoms of urinary tract infections (UTIs) or genital mycotic infections

Frequency: Regularly

Target: Not applicable

Action Threshold: If symptoms occur, promptly evaluate and treat.

Signs/symptoms of diabetic ketoacidosis (DKA)

Frequency: Regularly, especially in patients with risk factors.

Target: Not applicable

Action Threshold: If symptoms occur, discontinue Steglujan and evaluate for DKA.

Pancreatitis symptoms (e.g., severe abdominal pain)

Frequency: Regularly

Target: Not applicable

Action Threshold: If symptoms occur, discontinue Steglujan and investigate.

đŸ‘ī¸

Symptom Monitoring

  • Excessive thirst
  • Frequent urination
  • Dizziness or lightheadedness (especially when standing)
  • Fatigue
  • Nausea, vomiting, abdominal pain (potential DKA)
  • Unusual vaginal discharge or itching (genital mycotic infection)
  • Painful or frequent urination, fever, back pain (UTI)
  • Severe, persistent abdominal pain (pancreatitis)
  • Signs of hypoglycemia (sweating, tremor, confusion, hunger)

Special Patient Groups

🤰

Pregnancy

Contraindicated during the second and third trimesters of pregnancy due to potential adverse effects on renal development in the fetus (based on animal data with ertugliflozin). Limited human data on use in pregnancy.

Trimester-Specific Risks:

First Trimester: Limited data. Risk of major birth defects and miscarriage is not known.
Second Trimester: Potential for adverse renal effects in the developing fetus (renal tubular dilation and pelvicirenlargement) based on animal studies with SGLT2 inhibitors.
Third Trimester: Potential for adverse renal effects in the developing fetus (renal tubular dilation and pelvicirenlargement) based on animal studies with SGLT2 inhibitors.
🤱

Lactation

Not recommended during breastfeeding. It is unknown if ertugliflozin or sitagliptin are excreted in human milk. Due to the potential for serious adverse reactions in a breastfed infant, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Infant Risk: Unknown, but potential for adverse effects on infant renal development (ertugliflozin) or other unknown effects.
đŸ‘ļ

Pediatric Use

Safety and effectiveness have not been established in pediatric patients (under 18 years of age). Not recommended for use in this population.

👴

Geriatric Use

Use with caution in elderly patients (â‰Ĩ65 years of age) due to increased risk of volume depletion, orthostatic hypotension, and urinary tract infections. Renal function should be monitored more frequently. No dose adjustment is generally needed based on age alone, but consider renal function.

Clinical Information

💎

Clinical Pearls

  • Steglujan is a fixed-dose combination and should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis.
  • Prior to initiation, assess renal function (eGFR). Steglujan is contraindicated in patients with severe renal impairment (eGFR < 45 mL/min/1.73 m2), ESRD, or on dialysis.
  • Counsel patients on the signs and symptoms of diabetic ketoacidosis (DKA) and instruct them to seek immediate medical attention if these occur. Risk factors for DKA include acute illness, reduced caloric intake, surgery, and reduced insulin dose.
  • Advise patients to maintain adequate hydration to reduce the risk of volume depletion, especially during periods of illness or increased physical activity.
  • Educate patients on proper genital hygiene to minimize the risk of genital mycotic infections.
  • Discontinue Steglujan if pancreatitis is suspected.
  • Patients on insulin or sulfonylureas may require a dose reduction of these agents to minimize the risk of hypoglycemia when starting Steglujan.
🔄

Alternative Therapies

  • Other SGLT2 inhibitors (e.g., canagliflozin, dapagliflozin, empagliflozin)
  • Other DPP-4 inhibitors (e.g., saxagliptin, linagliptin, alogliptin)
  • GLP-1 receptor agonists (e.g., liraglutide, semaglutide)
  • Insulin
  • Sulfonylureas
  • Metformin
  • Thiazolidinediones (TZDs)
💰

Cost & Coverage

Average Cost: Varies, typically $500-$700 per 30 tablets
Insurance Coverage: Tier 2 or Tier 3 (preferred or non-preferred brand)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication.

This medication is accompanied by a Medication Guide, which provides crucial information about its use. Please read this guide carefully and review it again whenever you receive a refill of your medication. If you have any questions or concerns about this medication, don't hesitate to discuss them with your doctor, pharmacist, or other healthcare provider.

In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide details about the medication taken, the amount consumed, and the time it occurred.